Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein

Laboratory Investigation

Volumn 87, Issue 4, 2007, Pages 318-325

  Xia, Shujuan J ^a   Rajput, Prerna ^a,b   Strzelecki, Donna M ^a   Barr, Frederic G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Alveolar rhabdomyosarcoma; Chromosomal translocation; Gene fusion; Growth suppression; Transformation

Indexed keywords

AGAR; HYBRID PROTEIN; ONCOPROTEIN; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3;

ANIMAL CELL; ARTICLE; BIOASSAY; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; CARCINOGENICITY; CELL STRAIN 3T3; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION SYSTEM; GENE MUTATION; GENETIC TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RHABDOMYOSARCOMA;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; MUTATION; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; PAIRED BOX TRANSCRIPTION FACTORS; RHABDOMYOSARCOMA, ALVEOLAR; TRANSLOCATION, GENETIC;

EID: 33947531484     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700521     Document Type: Article

References (15)

1. Xia SJ, Pressey JG, Barr FG. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther 2002;1:97-104.
2. Barr FG. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 2001;20:5736-5746.
3. Davis RJ, Barr FG. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc Natl Acad Sci USA 1997;94:8047-8051.
4. Bennicelli JL, Edwards RH, Barr FG. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Proc Natl Acad Sci USA 1996;93:5455-5459.
5. del Peso L, Gonzalez VM, Hernandez R, et al. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 1999;18: 7328-7333.
6. Lam PY, Sublett JE, Hollenbach AD, et al. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain. Mol Cell Biol 1999;19:594-601.
7. Du S, Lawrence EJ, Strzelecki D, et al. Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma. Int J Cancer 2005;115:85-92.
8. Xia SJ, Barr FG. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. Oncogene 2004;23:6864-6871.
9. Barr FG, Xiong QB, Kelly K. A consensus polymerase chain reactionoligonucleotide hybridization approach for the detection of chromosomal translocations in pediatric bone and soft tissue sarcomas. Am J Clin Pathol 1995;104:627-633.
10. Bridge JA, Liu J, Qualman SJ, et al. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 2002;33:310-321.
11. Gordon AT, Brinkschmidt C, Anderson J, et al. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 2000;28:220-226.
12. Williamson D, Lu YJ, Gordon T, et al. Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype. J Clin Oncol 2005;23:880-888.
13. Berner JM, Forus A, Elkahloun A, et al. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 1996;17:254-259.
14. Baldwin CT, Hoth CF, Macina RA, et al. Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature. Am J Med Genet 1995;58:115-122.
15. Underhill DA, Gros P. The paired-domain regulates DNA binding by the homeodomain within the intact Pax-3 protein. J Biol Chem 1997;272:14175-14182.